Triple
T3582335
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Pacific Biosciences |
E75827
|
entity |
| Predicate | product |
P490
|
FINISHED |
| Object |
Revio System
The Revio System is a high-throughput long-read DNA sequencing platform developed by Pacific Biosciences for comprehensive genomic analysis.
|
E371072
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Revio System | Statement: [Pacific Biosciences, product, Revio System]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Revio System Context triple: [Pacific Biosciences, product, Revio System]
-
A.
Chessie System
Chessie System was a major American railroad holding company formed in the 1970s that operated several eastern U.S. railroads under the iconic “Chessie the cat” branding before eventually becoming part of CSX Transportation.
-
B.
Invetech
Invetech is a technology and product development company specializing in designing and engineering innovative medical and life science solutions.
-
C.
Efficeon
Efficeon is a family of low-power, x86-compatible microprocessors developed by Transmeta as the successor to its Crusoe line, aimed primarily at mobile and embedded computing devices.
-
D.
Renflexis
Renflexis is a biosimilar version of the monoclonal antibody infliximab, used to treat autoimmune conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
-
E.
Enova SF
Enova SF is a Norwegian state-owned enterprise that promotes energy efficiency, renewable energy, and reduced greenhouse gas emissions through funding and advisory programs.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Revio System Triple: [Pacific Biosciences, product, Revio System]
Generated description
The Revio System is a high-throughput long-read DNA sequencing platform developed by Pacific Biosciences for comprehensive genomic analysis.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Revio System Target entity description: The Revio System is a high-throughput long-read DNA sequencing platform developed by Pacific Biosciences for comprehensive genomic analysis.
-
A.
Chessie System
Chessie System was a major American railroad holding company formed in the 1970s that operated several eastern U.S. railroads under the iconic “Chessie the cat” branding before eventually becoming part of CSX Transportation.
-
B.
Invetech
Invetech is a technology and product development company specializing in designing and engineering innovative medical and life science solutions.
-
C.
Efficeon
Efficeon is a family of low-power, x86-compatible microprocessors developed by Transmeta as the successor to its Crusoe line, aimed primarily at mobile and embedded computing devices.
-
D.
Renflexis
Renflexis is a biosimilar version of the monoclonal antibody infliximab, used to treat autoimmune conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
-
E.
Enova SF
Enova SF is a Norwegian state-owned enterprise that promotes energy efficiency, renewable energy, and reduced greenhouse gas emissions through funding and advisory programs.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69ad85d6dc3c8190b491b79b83e25461 |
completed | March 8, 2026, 2:21 p.m. |
| NER | Named-entity recognition | batch_69adc102cb2881908fa4dc1bf6fa5961 |
completed | March 8, 2026, 6:33 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69b402f36b2481909d4716e72a696e0d |
completed | March 13, 2026, 12:28 p.m. |
| NEDg | Description generation | batch_69b403b9e7ac8190917e7313279b1c46 |
completed | March 13, 2026, 12:31 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69b4086f6da4819084778dffa33ef116 |
completed | March 13, 2026, 12:51 p.m. |
Created at: March 8, 2026, 3:21 p.m.